Early Complete Response as Validated Surrogate Marker in Extranodal Marginal Zone Lymphoma Systemic Therapy

Blood（2023）

引用 0|浏览3

暂无评分

摘要

Surrogate markers provide early decision-making endpoints for regulatory agencies since they intend to substitutes for long-term endpoints.

查看译文

关键词

lymphoma,validated surrogate marker,early complete response

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要